Organization · Venture Capital
Research Bridge Partners
Research Bridge Partners is a non-profit venture philanthropy organization that invests in biomedical startups emerging from mid-continent research universities in the United States. It aims to bridge the commercialization gap by providing seed funding and support to promising academic researchers.
Overview
What Research Bridge Partners does
What Research Bridge Partners is
Research Bridge Partners is a non-profit venture philanthropy organization that invests in biomedical startups emerging from mid-continent research universities in the United States. It aims to bridge the commercialization gap by providing seed funding and support to promising academic researchers.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Research Bridge Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Research Bridge Partners as a funder
Investment thesis
Research Bridge Partners focuses on making formative seed and scaling investments in biomedical startups emerging from mid-continent US research universities, bridging the commercialization gap between university innovators and national capital.
Focus narrative
Research Bridge Partners invests primarily in biomedical startups that leverage breakthroughs from mid-continent universities. The organization employs a unique approach by using proprietary analytics to identify promising academic researchers and collaborates with them to develop tailored capitalization strategies. By initiating seed investments and utilizing both tax-exempt and for-profit capital, Research Bridge Partners aims to support early-stage startups and enhance the commercialization of scientific research.
Value beyond capital
Research Bridge Partners provides unique value to its portfolio companies by offering venture-philanthropy-style patient capital, which is particularly beneficial for early-stage academic founders. The involvement of Reid Hoffman facilitates access to downstream commercialization resources in major venture hubs, enhancing the potential for successful exits and growth.
Terms and economics
- Typical check
- $250,000–$1,000,000
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
- Recorded notable exits
- Novosteo
Portfolio context
Research Bridge Partners has invested in approximately 8 portfolio companies over the past 6 years, with notable investments including Novosteo, a Purdue University spinout focused on bone-targeting therapeutics, and Tetricus Labs, their most recent investment in September 2023. Other portfolio companies include Erisyon, a UT Austin spinout specializing in single-molecule protein sequencing.
Common questions
What to know about Research Bridge Partners
Upseed classifies Research Bridge Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.